ERS · Barcelona · 2026-09-05 – 2026-09-09
ERS Congress 2026
0 di 11 studi Hot Line con risultatoI risultati sono sotto embargo fino a ciascuna presentazione e compaiono qui appena vengono resi noti.
sab 5 set
dom 6 set
ALERT 1: IMPACT — Implementation and intervention
08:30–10:00 · 3L08:30IMPACTImplementing predictive analytics towards efficient COPD treatments: a cluster randomised controlled trial
08:37Lung screening cessation surveyWillingness to engage in smoking cessation intervention among participants in a population-based lung cancer screening pilot
08:44IMP2ARTEffectiveness of a whole-systems strategy to improve implementation of supported asthma self-management in UK primary care
08:51PREVAILTargeted case-finding and proactive clinical management in primary care to reduce exacerbations in COPD
09:25COFIDENCEDiagnostic yield and safety of three endobronchial ultrasound-guided transbronchial biopsy techniques in mediastinal and hilar lymphadenopathy
09:32ARTICULAtEShape-sensing robotic-assisted bronchoscopy versus electromagnetic navigation bronchoscopy for peripheral pulmonary nodules
Endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer
13:45–14:30 · 1A14:00ERS2026 ERS/ESGE/ESTS guideline on endosonography for the diagnosis and staging of lung cancer
Management of patients with idiopathic pulmonary fibrosis and lung cancer
14:30–15:15 · 1A14:30ERSERS clinical practice guidelines on the management of idiopathic pulmonary fibrosis with lung cancer
lun 7 set
Continuous positive airway pressure for the treatment of adult obstructive sleep apnoea
09:15–10:00 · 3L09:35ERSNew ERS/ESRS clinical practice guideline for continuous positive airway pressure in adult obstructive sleep apnoea
From detection to decision: managing positive findings in lung cancer screening
13:45–14:30 · 3L14:05ERSERS/ESR/ESTI/ESTRO/ESTS/ELF patient-targeted guideline on screen-detected pulmonary nodules
Treatment of pulmonary arterial hypertension
14:30–15:15 · 3L14:30ERSERS clinical practice guidelines on the treatment of pulmonary arterial hypertension
mar 8 set
ALERT 2: Towards the golden age of respiratory science?
13:45–15:15 · 3B13:45OBERON and TITANIATozorakimab to prevent COPD exacerbations: results from the replicate OBERON and TITANIA phase 3 studies
13:52AIRCULESLunsekimig for patients with moderate-to-severe asthma
13:59ARRESTCombined aerosolised budesonide and formoterol for hospitalised patients with pneumonia and hypoxaemia
14:33BPD saturation trialTargeting higher versus lower oxygen saturation limits in preterm infants with bronchopulmonary dysplasia
14:40TIMBERLINESafety and efficacy of vanzacaftor/tezacaftor/deutivacaftor in children with cystic fibrosis aged 2 to 5 years